B R A H M S PCT sensitive KRYPTOR

FDA 510(k) K171338 · Brahms GmbH

Substantially Equivalent

510(k) numberK171338

Submission

Device name
B R A H M S PCT sensitive KRYPTOR
Applicant
Brahms GmbH
Henningsdorf, DE
Received
May 8, 2017
Decision date
May 31, 2017
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
PRI – Procalcitonin Assay
Device class
Class II (moderate risk)
Regulation
21 CFR 866.3215
Specialty
Microbiology

To aid in decision making on antibiotic therapy, including antibiotic initiation and discontinuation, for inpatients or patients in the Emergency Department, with suspected or confirmed lower respiratory tract infections (LRTI) defined as community-acquired pneumonia (CAP), acute bronchitis, and acute exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).

Other 510(k)s with product code PRI

510(k)DeviceApplicantDecision
K220262Dimension EXL LOCI BRAHMS Procalcitonin (PCT)PRI · Traditional Siemens Healthcare Diagnostics, Inc.08/26/2022SE
K192815Elecsys BRAHMS PCTPRI · Traditional Roche Diagnostics03/09/2020SE
K173927Elecsys BRAHMS PCTPRI · Traditional Roche Diagnostics07/06/2018SE
K173683LIAISON BRAHMS PCT II GEN, LIAISON Control BRAHMS PCT II GEN, LIAISON BRAHMS PCT II GEN…PRI · Traditional DiaSorin, Inc.02/27/2018SE
K172713Lumipulse G B•R•A•H•M•S PCT Immunoreaction Cartridges, Lumipulse G B•R•A•H•M•S PCT…PRI · Traditional Fujirebio Diagnostics,Inc.12/10/2017SE
K170652ARCHITECT B.R.A.H.M.S PCT, ARCHITECT B.R.A.H.M.S PCT Calibrators, ARCHITECT B.R.A.H.M.S…PRI · Traditional Fisher Diagnostics06/01/2017SE
K162827Vidas B.R.A.H.M.S. PCT (PCT)PRI · Traditional bioMerieux, Inc.02/23/2017SE

Questions and answers

When was B R A H M S PCT sensitive KRYPTOR cleared by the FDA?

B R A H M S PCT sensitive KRYPTOR (K171338) received a 510(k) decision of Substantially Equivalent on May 31, 2017, 23 days after the submission was received.

What is the product code of K171338?

The FDA product code is PRI – Procalcitonin Assay, a Class II (moderate risk) device regulated under 21 CFR 866.3215.